Alex Schwartz
Stock Analyst at Stifel
(1.83)
# 3,059
Out of 4,854 analysts
11
Total ratings
25%
Success rate
9.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Initiates: Buy | $50 | $21.14 | +136.52% | 4 | Feb 21, 2024 | |
| VTVT vTv Therapeutics | Downgrades: Hold | n/a | $16.16 | - | 2 | Apr 10, 2018 | |
| GERN Geron | Maintains: Hold | $2.5 → $4 | $1.56 | +156.41% | 1 | Mar 19, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $85 → $95 | $3.65 | +2,502.74% | 4 | Mar 9, 2018 |
AnaptysBio
Feb 21, 2024
Initiates: Buy
Price Target: $50
Current: $21.14
Upside: +136.52%
vTv Therapeutics
Apr 10, 2018
Downgrades: Hold
Price Target: n/a
Current: $16.16
Upside: -
Geron
Mar 19, 2018
Maintains: Hold
Price Target: $2.5 → $4
Current: $1.56
Upside: +156.41%
Puma Biotechnology
Mar 9, 2018
Maintains: Buy
Price Target: $85 → $95
Current: $3.65
Upside: +2,502.74%